News tagged with immunogens
Succesful results in developing oral vaccine against diarrhea
The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.
Medications
May 22, 2013 |
5 / 5 (1) |
0
First influenza vaccine brought to clinical testing
Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their ...
Medications
May 17, 2013 |
5 / 5 (1) |
1
Lyme disease vaccine shows promise in clinical trial
(Medical Xpress)—The results of a phase 1/2 clinical trial in Europe of an investigational Lyme disease vaccine co-developed by researchers at Stony Brook University, Brookhaven National Laboratory, and at Baxter International ...
Medications
May 13, 2013 |
not rated yet |
0
|
New study investigates fate and function of cells transplanted to the CNS
When different types of cells are transplanted with the intent of having them aid in repairing central nervous system (CNS) trauma, what is the fate and function of those cells? A Belgian research team carried out research ...
Medical research
Dec 20, 2012 |
not rated yet |
0
Positive early results in clinical trial of leukaemia vaccine
Early results of a trial to treat leukaemia with a WT1 DNA vaccine, has shown robust vaccine-specific antibody responses in all vaccinated patients evaluated to date.
Cancer
Dec 07, 2012 |
5 / 5 (1) |
0
Lexatumumab tolerated for pediatric solid tumors
(HealthDay)—Lexatumumab, an agonistic, full human monoclonal antibody against tumor necrosis factor-related apoptosis-inducing ligand receptor 2, is well tolerated and may lessen certain clinical symptoms ...
Cancer
Oct 16, 2012 |
5 / 5 (1) |
0
IDRI and Medicago announce authorization to initiate a Phase 1 clinical trial for an H5N1 vaccine
The Infectious Disease Research Institute (IDRI), a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc. (TSX: MDG; OTCQX: ...
Medications
Aug 16, 2012 |
not rated yet |
0
Reactions to HIV drug have autoimmune cause, reports AIDS journal
Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body's immune system, according ...
HIV & AIDS
May 22, 2012 |
5 / 5 (1) |
0
Experimental vaccine elicits robust response against both HIV and tuberculosis
Clinician researchers in China have developed a vaccine that acts simultaneously against HIV-1 and M. tuberculosis (Mtb). An estimated 14 million people worldwide are coinfected with the two pathogens. The research is published ...
Immunology
May 22, 2012 |
5 / 5 (1) |
0
Administration of meningococcal vaccine with other routine infant vaccines appears effective
Administration of routine infant immunizations with a vaccine for serogroup B Neisseria meningitidis, a bacterium that is a cause of serious disease such as sepsis and meningitis, was effective against meningococcal strains ...
Diseases, Conditions, Syndromes
Feb 07, 2012 |
5 / 5 (1) |
0
|
IADR/AADR publish study on dental caries vaccine
In a report on a preclinical investigation titled "Flagellin Enhances Saliva IgA Response and Protection of Anti-caries DNA Vaccine," lead author Wei Shi, Wuhan Institute of Virology, Chinese Academy of Sciences, and his ...
Other
Oct 25, 2011 |
not rated yet |
0
Lengthening dosing schedule of HPV vaccine may provide effective option for expanding use of vaccine
Administration of human papillomavirus (HPV) vaccine doses over a longer period of time to adolescent girls in Vietnam resulted in antibody concentration levels that were comparable to the standard vaccine schedule, according ...
Diseases, Conditions, Syndromes
Apr 12, 2011 |
not rated yet |
1
